Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution
SHANGHAI, April 28, 2026 /PRNewswire/ -- On 28 April, Fosun Pharma ("the Company", stock code: 600196.SH; 02196.HK) announced its results for the first quarter of 2026 (the reporting period). During the reporting period, the Company achieved a total...
Joyson Electronics Announces Q1 2026 Results: Strong Orders of RMB 27.5 billion, Net Profit Attributable to Shareholders up Nearly 20% YoY
HONG KONG and NINGBO, China, April 27, 2026 /PRNewswire/ -- Joyson Electronics (699.HK) announced financial results for Q1 2026 on April 27. Revenue for the period reached approximately RMB 13.8 billion, profit attributable to shareholders was...
A Paradise Acquisition Corp. Announces Intention to Voluntarily Delist from The Nasdaq Stock Market LLC, Conditional Upon Consummation of its Pending Business Combination with Enhanced Ltd
NEW YORK and HONG KONG, April 28, 2026 /PRNewswire/ -- A Paradise Acquisition Corp. (the "Company") today announced that, in connection with a proposed business combination (the "Business Combination") between the Company, A Paradise Merger Sub I,...
Republic Power Group Limited Announces Strategic Investment and Technology Access Agreement to Enter High-Growth RWA Tokenization and Blockchain Infrastructure Markets
Transaction Marks First Phase of RPGL's Expanded Digital Asset Strategy, Providing Equity Stake in NVC Partners and Institutional-Grade RWA Platform Capabilities SINGAPORE, April 27, 2026 /PRNewswire/ -- Republic Power Group Limited (NASDAQ: RPGL)...
Cellenkos, Inc. Announces FDA Clearance to Initiate Phase 2 Clinical Trial of CK0801 (Allogeneic Cord Blood-Derived Tregs) for Aplastic Anemia
Phase 2 multicenter, open-label study (NCT07499102) will evaluate the safety and clinical efficacy of CK0801 Tregs in transfusion-dependent aplastic anemia. HOUSTON, April 27, 2026 /PRNewswire/ -- Cellenkos®, Inc., a clinical-stage biotechnology...
AHG Announces Initiation of World-Class, Proprietary Brain-Computer Interface R&D Program - Targeting the Next Frontier of Human Neurotechnology
QINGDAO, China, April 27, 2026 /PRNewswire/ -- Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the commencement of its next-generation, proprietary Brain-Computer Interface (BCI) technology research and development...
Lufax Announces New Chief Compliance Officer Hire
SHANGHAI, April 27, 2026 /PRNewswire/ -- Lufax Holding Ltd (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners in China, today announced that it has appointed Ms. Xiaodi Wang as the Chief Compliance Officer of...
Agoda Announces Asia's Top Family Activities for 2026, Shanghai Disneyland Tops the Chart
SINGAPORE, April 27, 2026 /PRNewswire/ -- As summer draws near and families eagerly start planning their holidays, activities and experiences remain at the heart of crafting a memorable family summer vacation. Digital travel platform Agoda reveals...
Pony.ai Announces New Generation Autonomous Driving Compute Platform Built on NVIDIA DRIVE Hyperion
GUANGZHOU, China, April 25, 2026 /PRNewswire/ -- Pony AI Inc. ("Pony.ai") (NASDAQ: PONY; HKEX: 2026) today announced its new generation autonomous driving domain controller, a high-performance compute system designed for both Pony.ai's L4 autonomous...
NYSE Content Update: AI Company Vast Data Announces $30 Billion Valuation
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, April 24, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE...